Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
Charnley N, West CM, Barnett CM, Brock C, Bydder GM, Glaser M, Newlands ES, Swindell R, Matthews J, Price P. Charnley N, et al. Among authors: newlands es. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):331-8. doi: 10.1016/j.ijrobp.2006.04.043. Epub 2006 Jul 12. Int J Radiat Oncol Biol Phys. 2006. PMID: 16839701
Emerging targeted treatments for malignant glioma.
Mulholland PJ, Thirlwell C, Brock CS, Newlands ES. Mulholland PJ, et al. Among authors: newlands es. Expert Opin Emerg Drugs. 2005 Nov;10(4):845-54. doi: 10.1517/14728214.10.4.845. Expert Opin Emerg Drugs. 2005. PMID: 16262566 Review.
205 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page